Get startedLog in
    Picture of Newbury Pharmaceuticals AB logo

    NEWBRY — Newbury Pharmaceuticals AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    Consumer DefensivesHighly SpeculativeMicro CapMomentum Trap
    All News

    Brief: Newbury Pharmaceuticals Q4 EBITDA Turns To Profit Of SEK 2.4 Mln

    Picture of Newbury Pharmaceuticals AB logoNewbury Pharmaceuticals AB
    23/10/2024 14:19
    Oct 23 (Reuters) - Newbury Pharmaceuticals AB  NEWBRY.ST :
    * Q4 NET REVENUE SEK 21.1 MILLION VERSUS SEK 2.8 MILLION YEAR AGO
    * Q4 EBITDA SEK 2.4 MILLION VERSUS LOSS SEK 4.5 MILLION YEAR AGO
    * IN THIS QUARTER (JUNE-AUGUST) WE HAVE ACHIEVED OUR 2024 GOAL OF A POSITIVE EBITDA

Source text for Eikon:  ID:nMFN6fDnm 
Further company coverage:  NEWBRY.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Newbury Pharmaceuticals AB

    See all news